Evidence map›Paper›PMID 20004934›Full record

ArticleHuman pathology2010

Defining the borders of splenic marginal zone lymphoma: a multiparameter study.

Scott D Dufresne, Raymond E Felgar, Rachel L Sargent, Urvashi Surti, Susanne M Gollin, Ellen D McPhail, James R Cook, Steven H Swerdlow

Open access · greenAbstract read
In one paragraph

Article in Human pathology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 34 citations in OpenAlex.

  1. Follicular lymphoma and marginal zone lymphoma: how many diseases?Virchows Archiv : an international journal of pathology · 2023
    Review
  2. A Review on Splenic Diffuse Red Pulp Small B-Cell Lymphoma.Current oncology (Toronto, Ont.) · 2021
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2015
    Article
  8. Unusual Course of Splenic Marginal Zone Lymphoma.World journal of oncology · 2013
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Scott D DufresneDepartment of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
Raymond E Felgar
Rachel L Sargent
Urvashi Surti
Susanne M Gollin
Ellen D McPhail
James R Cook
Steven H Swerdlow
University of Pittsburgh · USMagee-Womens Hospital · USCleveland Clinic · USMayo Clinic · US

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Jessie Nedrow · 1988 to 2026
$158.0M
University of Pittsburgh Clinical and Translational Science InstituteUL1TR000005 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$50.8M
Characterization of the 11q13 Amplicon in Oral CancerR01DE014729 · NIDCR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GOLLIN, SUSANNE M · 2002 to 2006
$1.7M
NCATS NIH HHS UL1 TR000005NCI NIH HHS P30 CA047904NCI NIH HHS P30CA047904NIDCR NIH HHS R01 DE014729
6 · The paper itself

Abstract

Classic splenic marginal zone lymphomas are CD5-, CD10-, CD23-, CD43-, and usually IgD+ with biphasic white pulp nodules. However, the 2008 World Health Organization classification accepts splenic marginal zone lymphomas with monophasic marginal zone-like white pulp nodules and recognizes a group of unclassifiable splenic small B-cell lymphomas. To explore the relationship of classic splenic marginal zone lymphomas to these other less well-defined splenic lymphomas, a multiparameter study of 47 splenic marginal zone lymphomas and unclassifiable splenic small B-cell lymphomas was performed. Seventeen of 31 splenic marginal zone lymphomas were biphasic, and 14 were monophasic (90%-100% marginal zone-like white pulp nodules). Sixteen cases were unclassifiable splenic small B-cell lymphomas, most lacking a marginal zone-type component. There were many clinical similarities between the 3 groups, including similar survivals. Monophasic and unclassifiable cases were less likely to have a typical splenic marginal zone lymphoma phenotype (28.6%, 23.1%) compared with biphasic cases (86.7%), usually because of IgD negativity (P < .003). Thirty-four of 42 (81%) cases had cytogenetic abnormalities by fluorescence in situ hybridization; and 17 of 20 (85%), by classical cytogenetics. The most frequent fluorescence in situ hybridization abnormalities among the splenic marginal zone lymphomas were del(7)(q31) (26%), +12 (25%), and +3q27 (27%); and among the unclassifiable cases, +12 (50%) and +3q27 (36%). Five of 6 unclassifiable cases with exclusively small non-marginal zone-like lymphocytes involving both white and red pulp had +12 compared with 9 of 34 other cases (P < .02). CDK6 (2 cases) and BCL3 (1 case) rearrangements were only seen in the unclassifiable group. These results support including both biphasic and monophasic cases as splenic marginal zone lymphomas, but suggest that the lack of a non-marginal zone-like population in the monophasic group is associated with some biologic differences. They also demonstrate a relatively large proportion of unclassifiable cases, including a group with frequent +12.

Indexed as

AgedFemaleHumansImmunohistochemistryIn Situ Hybridization, FluorescenceLymphoma, B-Cell, Marginal ZoneMaleMiddle AgedSplenic Neoplasms

Identifiers

PMID20004934
PMCPMC2879876
OpenAlexW2053070096

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.